Vaccination against mycobacterial diseases in animals / topic editors: John P. Bannantine and Adel M. Talaat.
The two most prominent mycobacterial diseases in animals include bovine tuberculosis, caused by Mycobacterium bovis and Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis. Erradication of both diseases has been hampered by a variety of factors. In many countries, the persiste...
Saved in:
Superior document: | Frontiers in cellular and infection microbiology |
---|---|
: | |
TeilnehmendeR: | |
Place / Publishing House: | [Lausanne, Switzerland] : : Frontiers Media SA,, 2015. |
Year of Publication: | 2015 |
Language: | English |
Series: | Frontiers Research Topics
Frontiers in cellular and infection microbiology |
Physical Description: | 1 online resource (94 pages) :; illustrations; digital, PDF file(s). |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548074404498 |
---|---|
ctrlnum |
(CKB)3710000000612073 (oapen)https://directory.doabooks.org/handle/20.500.12854/61820 (EXLCZ)993710000000612073 |
collection |
bib_alma |
record_format |
marc |
spelling |
John P. Bannantine auth Vaccination against mycobacterial diseases in animals [electronic resource] / topic editors: John P. Bannantine and Adel M. Talaat. Frontiers Media SA 2015 [Lausanne, Switzerland] : Frontiers Media SA, 2015. 1 online resource (94 pages) : illustrations; digital, PDF file(s). text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Frontiers Research Topics Frontiers in cellular and infection microbiology Includes bibliographical references. The two most prominent mycobacterial diseases in animals include bovine tuberculosis, caused by Mycobacterium bovis and Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis. Erradication of both diseases has been hampered by a variety of factors. In many countries, the persistence of tuberculosis in cattle has been attributed to reservoirs of M. bovis in wildlife species. Brushtail possums, deer and badgers are notable examples of wildlife reservoirs for M. bovis. The difficulties in eliminating the wildlife reservoir for M. bovis further suggest the need for vaccination of farmed livestock. Vaccination of wildlife species has also been attempted with mixed results. Delivery of the vaccine to wildlife species appears to be a chief obstacle. Vaccination itself leads to complications for diagnostics. For example, when cattle are vaccinated with both BCG and a commercial Johne’s vaccine there is a biased toward the avian tuberculin skin test reaction. Despite these issues, BCG seems to be the clear standard for vaccination against M. bovis, yet many laboratories are investigating ways to improve on BCG. For Johne’s disease, the available commercial vaccines consist of whole-cell preparations in one form or another. But with the ability to generate directed knockouts of specific genes, a number of defined mutants have been constructed in a few laboratories. These should be tested and directly compared with each other and alongside commercial vaccine formulations to determine not only which vaccine is most protective, but which animal model is best for predicting protection in the target host. To this end, there has been a nation-wide, multi-institutional effort to test the best live, attenuated vaccine against Johne's disease in cattle, sheep and goats. This vaccine trial has spanned six years and was conducted in three phases. The first phase examined attenuation in bovine macrophages, the second phase was colonization of spleen and liver in mice and the third phase was protection from bacterial challenge in goats. Many new ideas and retrospective approaches have emerged from this unprecedented effort. These aspects will be captured in this Research Topic. In this Research Topic, we will seek articles on these above topics, but other issues surrounding vaccination of animals against mycobacteria will also be explored. These include immune parameters, correlates of protection, adjuvants and other vaccine formulations, etc. Description based on e-publication, viewed on April 12, 2019. English Veterinary vaccines. Bacterial vaccines. Tuberculosis in cattle Prevention. Bacterial Vaccines immunology. goat trial correlates of protection Paratuberculosis Johne's disease Attenuated mutant Vaccine Bannantine, John P., editor. Talaat, Adel M., editor. 2-88919-476-0 |
language |
English |
format |
Electronic eBook |
author |
John P. Bannantine |
spellingShingle |
John P. Bannantine Vaccination against mycobacterial diseases in animals Frontiers Research Topics Frontiers in cellular and infection microbiology |
author_facet |
John P. Bannantine Bannantine, John P., Talaat, Adel M., |
author_variant |
j p b jpb |
author2 |
Bannantine, John P., Talaat, Adel M., |
author2_variant |
j p b jp jpb a m t am amt |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
John P. Bannantine |
title |
Vaccination against mycobacterial diseases in animals |
title_full |
Vaccination against mycobacterial diseases in animals [electronic resource] / topic editors: John P. Bannantine and Adel M. Talaat. |
title_fullStr |
Vaccination against mycobacterial diseases in animals [electronic resource] / topic editors: John P. Bannantine and Adel M. Talaat. |
title_full_unstemmed |
Vaccination against mycobacterial diseases in animals [electronic resource] / topic editors: John P. Bannantine and Adel M. Talaat. |
title_auth |
Vaccination against mycobacterial diseases in animals |
title_new |
Vaccination against mycobacterial diseases in animals |
title_sort |
vaccination against mycobacterial diseases in animals |
series |
Frontiers Research Topics Frontiers in cellular and infection microbiology |
series2 |
Frontiers Research Topics Frontiers in cellular and infection microbiology |
publisher |
Frontiers Media SA Frontiers Media SA, |
publishDate |
2015 |
physical |
1 online resource (94 pages) : illustrations; digital, PDF file(s). |
isbn |
2-88919-476-0 |
illustrated |
Illustrated |
work_keys_str_mv |
AT johnpbannantine vaccinationagainstmycobacterialdiseasesinanimals AT bannantinejohnp vaccinationagainstmycobacterialdiseasesinanimals AT talaatadelm vaccinationagainstmycobacterialdiseasesinanimals |
status_str |
n |
ids_txt_mv |
(CKB)3710000000612073 (oapen)https://directory.doabooks.org/handle/20.500.12854/61820 (EXLCZ)993710000000612073 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers in cellular and infection microbiology |
is_hierarchy_title |
Vaccination against mycobacterial diseases in animals |
container_title |
Frontiers in cellular and infection microbiology |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796649042954944512 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04198nam a2200481 i 4500</leader><controlfield tag="001">993548074404498</controlfield><controlfield tag="005">20230621141033.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#mu#---uuuuu</controlfield><controlfield tag="008">160314s2015uuuusz ad||fob 000-0|eng|d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000612073</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61820</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000612073</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="d">UkMaJRU</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">John P. Bannantine</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Vaccination against mycobacterial diseases in animals</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">topic editors: John P. Bannantine and Adel M. Talaat.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2015</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Lausanne, Switzerland] :</subfield><subfield code="b">Frontiers Media SA,</subfield><subfield code="c">2015.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (94 pages) :</subfield><subfield code="b">illustrations; digital, PDF file(s).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers in cellular and infection microbiology</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">The two most prominent mycobacterial diseases in animals include bovine tuberculosis, caused by Mycobacterium bovis and Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis. Erradication of both diseases has been hampered by a variety of factors. In many countries, the persistence of tuberculosis in cattle has been attributed to reservoirs of M. bovis in wildlife species. Brushtail possums, deer and badgers are notable examples of wildlife reservoirs for M. bovis. The difficulties in eliminating the wildlife reservoir for M. bovis further suggest the need for vaccination of farmed livestock. Vaccination of wildlife species has also been attempted with mixed results. Delivery of the vaccine to wildlife species appears to be a chief obstacle. Vaccination itself leads to complications for diagnostics. For example, when cattle are vaccinated with both BCG and a commercial Johne’s vaccine there is a biased toward the avian tuberculin skin test reaction. Despite these issues, BCG seems to be the clear standard for vaccination against M. bovis, yet many laboratories are investigating ways to improve on BCG. For Johne’s disease, the available commercial vaccines consist of whole-cell preparations in one form or another. But with the ability to generate directed knockouts of specific genes, a number of defined mutants have been constructed in a few laboratories. These should be tested and directly compared with each other and alongside commercial vaccine formulations to determine not only which vaccine is most protective, but which animal model is best for predicting protection in the target host. To this end, there has been a nation-wide, multi-institutional effort to test the best live, attenuated vaccine against Johne's disease in cattle, sheep and goats. This vaccine trial has spanned six years and was conducted in three phases. The first phase examined attenuation in bovine macrophages, the second phase was colonization of spleen and liver in mice and the third phase was protection from bacterial challenge in goats. Many new ideas and retrospective approaches have emerged from this unprecedented effort. These aspects will be captured in this Research Topic. In this Research Topic, we will seek articles on these above topics, but other issues surrounding vaccination of animals against mycobacteria will also be explored. These include immune parameters, correlates of protection, adjuvants and other vaccine formulations, etc.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on e-publication, viewed on April 12, 2019.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Veterinary vaccines.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bacterial vaccines.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tuberculosis in cattle</subfield><subfield code="x">Prevention.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Bacterial Vaccines</subfield><subfield code="x">immunology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">goat trial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">correlates of protection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Paratuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Johne's disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Attenuated mutant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Vaccine</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bannantine, John P.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Talaat, Adel M.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-476-0</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-25 14:15:18 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2016-03-17 15:52:20 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338724780004498&Force_direct=true</subfield><subfield code="Z">5338724780004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338724780004498</subfield></datafield></record></collection> |